Vallo Stefan, Wirth Patrick, Kukic Adnan, Nafez Omar, Neagoe Ladislau, Nestler Sebastian, Jones Jon
Department of Urology, Hochtaunus-Kliniken, Bad Homburg, Germany.
Urologie an der Zeil, Frankfurt am Main, Germany.
Curr Urol. 2022 Jun;16(2):94-98. doi: 10.1097/CU9.0000000000000079. Epub 2022 Jan 11.
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide and have become more difficult to treat over the years. Inappropriate antibiotic use has led to increased antibiotic resistance.
We examined 1921 urine culture samples from a single hospital and analyzed them for bacterial spectrum and antibiotic susceptibility. We further analyzed changes in the rates of detected bacteria and of the sensitivity of these uropathogens to antibiotics over the years.
In our hospital-based analysis, cystitis was the most frequently diagnosed UTI in women (76%) and men (79%). (48%) was the most commonly identified uropathogen. Samples demonstrated an increase in the proportion of 0.001) and a decrease in 0.001) over the study time period. Antimicrobial susceptibility analysis showed an increase over time in the number of isolates with resistance to ampicillin/sulbactam 0.001) and to third-generation cephalosporins cefotaxime 0.043) and ceftazidime 0.001).
Ampicillin/sulbactam and third-generation cephalosporins are antibiotics frequently used in the treatment of UTIs. When selecting an optimal antimicrobial treatment regimen for patients with UTIs, it is imperative to understand regional and timedependent differences in the prevalence of various uropathogens and antimicrobial resistance patterns. Therefore, continuous surveillance of local pathogen and antimicrobial susceptibility patterns for frequently used antibiotics should be prioritized.
尿路感染(UTIs)是全球最常见的细菌感染之一,多年来治疗难度越来越大。抗生素使用不当导致抗生素耐药性增加。
我们检查了一家医院的1921份尿培养样本,并分析了其细菌谱和抗生素敏感性。我们还进一步分析了多年来检测到的细菌率以及这些尿路病原体对抗生素敏感性的变化。
在我们基于医院的分析中,膀胱炎是女性(76%)和男性(79%)中最常诊断出的UTI。大肠埃希菌(48%)是最常鉴定出的尿路病原体。在研究时间段内,样本显示肺炎克雷伯菌的比例增加(P<0.001),而大肠埃希菌的比例下降(P<0.001)。抗菌药物敏感性分析显示,对氨苄西林/舒巴坦耐药的分离株数量随时间增加(P<0.001),对第三代头孢菌素头孢噻肟(P<0.043)和头孢他啶(P<0.001)耐药的分离株数量也随时间增加。
氨苄西林/舒巴坦和第三代头孢菌素是治疗UTIs常用的抗生素。在为UTIs患者选择最佳抗菌治疗方案时,必须了解各种尿路病原体流行率和抗菌药物耐药模式的地区差异和时间依赖性差异。因此,应优先持续监测当地病原体和常用抗生素的抗菌药物敏感性模式。